| Literature DB >> 20888737 |
Sonja von Campenhausen1, Yaroslav Winter, Antonio Rodrigues e Silva, Christina Sampaio, Evzen Ruzicka, Paolo Barone, Werner Poewe, Alla Guekht, Céu Mateus, Karl-P Pfeiffer, Karin Berger, Jana Skoupa, Kai Bötzel, Sabine Geiger-Gritsch, Uwe Siebert, Monika Balzer-Geldsetzer, Wolfgang H Oertel, Richard Dodel, Jens P Reese.
Abstract
We investigated the costs of Parkinson's Disease (PD) in 486 patients based on a survey conducted in six countries. Economic data were collected over a 6-month period and presented from the societal perspective. The total mean costs per patient ranged from EUR 2620 to EUR 9820. Direct costs totalled about 60% to 70% and indirect costs about 30% to 40% of total costs. The proportions of costs components of PD vary notably; variations were due to differences in country-specific health system characteristics, macro economic conditions, as well as frequencies of resource use and price differences. However, inpatient care, long-term care and medication were identified as the major expenditures in the investigated countries.Entities:
Mesh:
Substances:
Year: 2011 PMID: 20888737 DOI: 10.1016/j.euroneuro.2010.08.002
Source DB: PubMed Journal: Eur Neuropsychopharmacol ISSN: 0924-977X Impact factor: 4.600